NCT03156725

Brief Summary

The objective of this study was to compare the absorption of a new iron product, iron enriched Aspergillus oryzae to ferrous sulfate in humans using a double stable-isotope technique.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2014

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 19, 2014

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 14, 2014

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 4, 2016

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 12, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 17, 2017

Completed
Last Updated

May 17, 2017

Status Verified

May 1, 2017

Enrollment Period

4 months

First QC Date

May 12, 2017

Last Update Submit

May 15, 2017

Conditions

Keywords

Iron Bioavailabilityhepcidinferritiniron absorptioniron status

Outcome Measures

Primary Outcomes (1)

  • iron absorption

    Isotope enrichment in the blood samples

    15 days

Secondary Outcomes (1)

  • iron status

    15 days

Study Arms (2)

Ferrous Sulfate

EXPERIMENTAL

The ferrous sulfate group was required to consume a test containing ferrous sulfate (10 mg of 57Fe). Participants received a meal containing 17.6 g egg albumin, 45 g corn syrup solids, 17.5 g corn oil, 6 ml vanilla extract, and 100 ml of distilled water.

Drug: Ferrous Sulfate

Aspiron

EXPERIMENTAL

The Asprion group was required to follow the same protocol as the 57Fe experimental group, with the exception of taking A. Oryzae containing (8 mg natural abundace Fe and 2 mg 58Fe. Meals composition was similar to ferrous sulafte group.

Dietary Supplement: Aspiron

Interventions

Ferrous Sulfate
AspironDIETARY_SUPPLEMENT
Aspiron

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Marginal iron status (Serum ferritin \<30ug/L)
  • BMI in the range 18.5-24.9 kg/m2
  • Willing to discontinue vitamin and mineral supplements 2 weeks prior and during the study
  • Willing to consume stable iron isotope labelled supplement
  • Willing to stop getting blood drawn 2 weeks prior to the study and during the study
  • Willing to give multiple blood samples at beginning and end of study

You may not qualify if:

  • Pregnant
  • Lactating
  • Smoker
  • Anemic (hemoglobin \< 120 g/L)
  • Has gastro-intestinal disease/condition that can affect absorption
  • Allergic to any of the meal components

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

ferrous sulfate

Study Officials

  • Manju B Reddy, PhD

    Iowa State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
When 57Fe was added to a meal an empy capsule was consumed by the subjects. 58Fe and natutal abundace iron associated with A. oryzae was consumed in capsule form.
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Subjects were two meals on two consecutive days with the stable isotopes.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 12, 2017

First Posted

May 17, 2017

Study Start

May 19, 2014

Primary Completion

September 14, 2014

Study Completion

June 4, 2016

Last Updated

May 17, 2017

Record last verified: 2017-05

Data Sharing

IPD Sharing
Will not share

Publication in a journal